BEDFORD, Mass.--(BUSINESS WIRE)--
Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics
medicines company specializing in therapeutics based on its proprietary hyaluronic
acid ("HA") technology, today announced the appointment of
Thomas M. Finnerty as its Chief Human Resources Officer. Mr. Finnerty
brings a 25-year track record of building global human resources teams,
and specializes in talent acquisition and development, executive
coaching, and employee engagement. After spending the last three months
in a strategic human capital consulting role with Anika, Mr. Finnerty
will transition to this newly-created position on October 30, 2017. He
will be responsible for spearheading strategic talent acquisitions at
Anika's U.S. and European headquarters, and overseeing professional
development and employee relations initiatives.
"As we build out our commercial operations and expand our global
footprint, talent acquisition and retention will be of critical
importance," said Charles H. Sherwood, Ph.D., Chief Executive Officer of
Anika Therapeutics. "We are pleased to strengthen our executive
leadership team with a seasoned human resources specialist like Mr.
Finnerty. With more than two decades of expertise leading human
resources operations for global medical device companies, Tom is
well-positioned to support Anika's next decade of growth."
Most recently, Mr. Finnerty spent 17 years as Senior Vice President of
Human Resources at Smith & Nephew, a global medical device leader with
14,000 employees worldwide. Prior to his time at Smith & Nephew, Mr.
Finnerty served as Executive Director of Human Resources at
"Anika is on the cusp of a major transformation, and joining the
executive team as the human resources lead presents an exciting
opportunity to further expand and build out its human capital programs
and initiatives," said Thomas M. Finnerty, Chief Human Resources Officer
of Anika Therapeutics.
Mr. Finnerty began his human resources career at The Foxboro Company, a
global enterprise focused on designing and manufacturing innovative
process control products and systems. He holds a Masters in Business
Administration from Babson College, and Bachelor of Science in Business
from the University of Massachusetts.
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic
medicines company based in Bedford, Massachusetts. Anika is committed to
improving the lives of patients with degenerative orthopedic diseases
and traumatic conditions with clinically meaningful therapies along the
continuum of care, from palliative pain management to regenerative
cartilage repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20 products
based on its proprietary hyaluronic
acid (HA) technology. Anika's orthopedic medicine portfolio includes ORTHOVISC®, MONOVISC®,
which alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST®,
a solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171023006268/en/
For Investor Inquiries:
Anika Therapeutics, Inc.
Chief Financial Officer
Sonal Vasudev, 917-523-1418
Source: Anika Therapeutics, Inc.
News Provided by Acquire Media